Person

David Baltimore

Formerly Director, Amgen

Current S&P 500 boards
0
Current roles
0
Open-market buys
$0
Open-market sales
$1.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

No current S&P 500 role.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • AMGN
    Amgen
    Director
    2016 or earlier – last filing May 2018

Sits alongside

People who currently share a board or management team with this person.

No current colleagues on record.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
May 31, 2017AMGNSale3,700$153.93$570K
Apr 29, 2016AMGNSale3,312$157.21$521K

SEC reporting-owner ID (CIK) 1185858 · all filings on EDGAR

David Baltimore | USBoard